Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 5/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | AVPR1A | P37288 | 8/20 | 0.40 |
| ▸ | NMT1 | P30419 | 2/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4901689 | 0.99 | AVPR1B (0.42) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL22139318 | 0.94 | AVPR1B (0.43) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL30038580 | 0.94 | AVPR1B (0.43) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL24136539 | 0.94 | AVPR1B (0.43) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL18468371 | 0.90 | AVPR1B (0.45) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL29918117 | 0.90 | AVPR1B (0.41) | AVPR1BF2AVPR1ANMT1PLG | |
| SCHEMBL28823513 | 0.90 | AVPR1B (0.41) | AVPR1BF2AVPR1ANMT1PLG | |
| Hydrochloric Acid SCHEMBL29918226 | 0.89 | AVPR1B (0.40) | AVPR1BF2AVPR1ANMT1PLG | |
| Hydrochloric Acid SCHEMBL18049425 | 0.88 | AVPR1B (0.42) | AVPR1BF2AVPR1ANMT1PLG | |
| Hydrochloric Acid SCHEMBL19923044 | 0.88 | AVPR1B (0.42) | AVPR1BF2AVPR1ANMT1PLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280920-A1 | Plasminogen Activator Inhibitor-1 Inhibitors | AMERICAN DIAGNOSTICA INC. | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280920-A1 | Plasminogen Activator Inhibitor-1 Inhibitors | SERPINE1, SERPINC1, SERPINB1 | AVPR1B 1428/4885F2 21/4885AVPR1A 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.